
Mohammad M. Hoque
Examiner (ID: 9407, Phone: (571)272-6266 , Office: P/2817 )
| Most Active Art Unit | 2817 |
| Art Unit(s) | 2817, 2823 |
| Total Applications | 844 |
| Issued Applications | 653 |
| Pending Applications | 100 |
| Abandoned Applications | 113 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14343003
[patent_doc_number] => 20190153474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => CNS GENE DELIVERY USING PERIPHERAL ADMINISTRATION OF AAV VECTORS
[patent_app_type] => utility
[patent_app_number] => 16/214214
[patent_app_country] => US
[patent_app_date] => 2018-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16214214
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/214214 | CNS GENE DELIVERY USING PERIPHERAL ADMINISTRATION OF AAV VECTORS | Dec 9, 2018 | Abandoned |
Array
(
[id] => 14620103
[patent_doc_number] => 20190223418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => NON-HUMAN ANIMALS HAVING AN ENGINEERED IMMUNOGLOBULIN LAMBDA LIGHT CHAIN AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/209820
[patent_app_country] => US
[patent_app_date] => 2018-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79210
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16209820
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/209820 | Mouse having an engineered immunoglobulin lambda light chain | Dec 3, 2018 | Issued |
Array
(
[id] => 14371047
[patent_doc_number] => 20190159436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => NON-HUMAN ANIMALS COMPRISING A HUMANIZED TRKB LOCUS
[patent_app_type] => utility
[patent_app_number] => 16/206330
[patent_app_country] => US
[patent_app_date] => 2018-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16206330
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/206330 | Genetically modified rat comprising a humanized | Nov 29, 2018 | Issued |
Array
(
[id] => 14338821
[patent_doc_number] => 20190151383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => SIGNAL-SMART ONCOLYTIC VIRUSES IN TREATMENT OF HUMAN CANCERS
[patent_app_type] => utility
[patent_app_number] => 16/198578
[patent_app_country] => US
[patent_app_date] => 2018-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16198578
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/198578 | SIGNAL-SMART ONCOLYTIC VIRUSES IN TREATMENT OF HUMAN CANCERS | Nov 20, 2018 | Abandoned |
Array
(
[id] => 16358396
[patent_doc_number] => 20200315147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => NON-HUMAN ANIMAL AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 16/761911
[patent_app_country] => US
[patent_app_date] => 2018-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16761911
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/761911 | NON-HUMAN ANIMAL AND METHOD FOR PRODUCING SAME | Nov 18, 2018 | Abandoned |
Array
(
[id] => 19700063
[patent_doc_number] => 12194062
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Methods for non-myeloablative bone marrow reconstitution
[patent_app_type] => utility
[patent_app_number] => 16/191816
[patent_app_country] => US
[patent_app_date] => 2018-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 21134
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16191816
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/191816 | Methods for non-myeloablative bone marrow reconstitution | Nov 14, 2018 | Issued |
Array
(
[id] => 14015067
[patent_doc_number] => 20190069527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => MOUSE MODEL OF RETINAL DEGENERATION
[patent_app_type] => utility
[patent_app_number] => 16/181216
[patent_app_country] => US
[patent_app_date] => 2018-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9953
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16181216
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/181216 | MOUSE MODEL OF RETINAL DEGENERATION | Nov 4, 2018 | Abandoned |
Array
(
[id] => 14231169
[patent_doc_number] => 20190127757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => LONG GERMLINE DH GENES AND LONG HCDR3 ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 16/165018
[patent_app_country] => US
[patent_app_date] => 2018-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24009
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16165018
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/165018 | Long germline DH genes and long HCDR3 antibodies | Oct 18, 2018 | Issued |
Array
(
[id] => 19716142
[patent_doc_number] => 12201657
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => Adeno-associated virus compositions for restoring HBB gene function and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/163061
[patent_app_country] => US
[patent_app_date] => 2018-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 21
[patent_no_of_words] => 29206
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16163061
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/163061 | Adeno-associated virus compositions for restoring HBB gene function and methods of use thereof | Oct 16, 2018 | Issued |
Array
(
[id] => 19395697
[patent_doc_number] => 12070021
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-27
[patent_title] => Chimeric mouse comprising stably transplanted bat cells
[patent_app_type] => utility
[patent_app_number] => 16/650814
[patent_app_country] => US
[patent_app_date] => 2018-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 8034
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16650814
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/650814 | Chimeric mouse comprising stably transplanted bat cells | Sep 24, 2018 | Issued |
Array
(
[id] => 15678401
[patent_doc_number] => 20200093864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => NOVEL THERAPEUTIC STEM CELL COMPOSITIONS WITH AN ACTIVE OXIDATIVE PHOSPHORYLATION SITE AND THEIR PREPARATION
[patent_app_type] => utility
[patent_app_number] => 16/138898
[patent_app_country] => US
[patent_app_date] => 2018-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9641
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16138898
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/138898 | NOVEL THERAPEUTIC STEM CELL COMPOSITIONS WITH AN ACTIVE OXIDATIVE PHOSPHORYLATION SITE AND THEIR PREPARATION | Sep 20, 2018 | Abandoned |
Array
(
[id] => 16674616
[patent_doc_number] => 20210063379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => Customized Growth Factor Screening System for Cell Culture
[patent_app_type] => utility
[patent_app_number] => 16/644267
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16644267
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/644267 | Customized Growth Factor Screening System for Cell Culture | Sep 6, 2018 | Abandoned |
Array
(
[id] => 16696923
[patent_doc_number] => 10947506
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Human cardiovascular progenitor cells
[patent_app_type] => utility
[patent_app_number] => 16/059647
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 62
[patent_no_of_words] => 7712
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16059647
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/059647 | Human cardiovascular progenitor cells | Aug 8, 2018 | Issued |
Array
(
[id] => 15493335
[patent_doc_number] => 20200046856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => METHODS FOR IDENTIFYING MBLAC1-DEPENDENT MOLECULAR NETWORKS
[patent_app_type] => utility
[patent_app_number] => 16/057013
[patent_app_country] => US
[patent_app_date] => 2018-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20822
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16057013
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/057013 | METHODS FOR IDENTIFYING MBLAC1-DEPENDENT MOLECULAR NETWORKS | Aug 6, 2018 | Abandoned |
Array
(
[id] => 15990601
[patent_doc_number] => 20200171171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => GENE THERAPY FOR TREATMENT OF INFERTILITY
[patent_app_type] => utility
[patent_app_number] => 16/630589
[patent_app_country] => US
[patent_app_date] => 2018-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630589
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/630589 | GENE THERAPY FOR TREATMENT OF INFERTILITY | Jul 25, 2018 | Abandoned |
Array
(
[id] => 16839802
[patent_doc_number] => 20210147814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => METHODS FOR GENERATING PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 16/630420
[patent_app_country] => US
[patent_app_date] => 2018-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -58
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630420
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/630420 | METHODS FOR GENERATING PLURIPOTENT STEM CELLS | Jul 11, 2018 | Abandoned |
Array
(
[id] => 16839798
[patent_doc_number] => 20210147810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => SINGLE LUNG CELL-DERIVED ORGANOIDS
[patent_app_type] => utility
[patent_app_number] => 16/626059
[patent_app_country] => US
[patent_app_date] => 2018-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16626059
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/626059 | SINGLE LUNG CELL-DERIVED ORGANOIDS | Jun 27, 2018 | Abandoned |
Array
(
[id] => 13508237
[patent_doc_number] => 20180305661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => ISOLATION, EXPANSION AND USE OF CLONOGENIC ENDOTHELIAL PROGENITOR CELLS
[patent_app_type] => utility
[patent_app_number] => 16/020286
[patent_app_country] => US
[patent_app_date] => 2018-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16020286
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/020286 | ISOLATION, EXPANSION AND USE OF CLONOGENIC ENDOTHELIAL PROGENITOR CELLS | Jun 26, 2018 | Abandoned |
Array
(
[id] => 15861169
[patent_doc_number] => 20200137988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => FISH EGG PROCESSING APPARATUS
[patent_app_type] => utility
[patent_app_number] => 16/629396
[patent_app_country] => US
[patent_app_date] => 2018-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16629396
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/629396 | FISH EGG PROCESSING APPARATUS | Jun 24, 2018 | Abandoned |
Array
(
[id] => 14277811
[patent_doc_number] => 20190136190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => DIFFERENTIATION OF PLURIPOTENT STEM CELLS AND CARDIAC PROGENITOR CELLS INTO STRIATED CARDIOMYOCYTE FIBERS USING LAMININS LN-511, LN-521 AND LN-221
[patent_app_type] => utility
[patent_app_number] => 16/015336
[patent_app_country] => US
[patent_app_date] => 2018-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18235
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16015336
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/015336 | DIFFERENTIATION OF PLURIPOTENT STEM CELLS AND CARDIAC PROGENITOR CELLS INTO STRIATED CARDIOMYOCYTE FIBERS USING LAMININS LN-511, LN-521 AND LN-221 | Jun 21, 2018 | Pending |